{
    "eid": "2-s2.0-84958533104",
    "title": "Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma",
    "cover-date": "2016-03-23",
    "subject-areas": [
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        },
        {
            "$": "Pharmacology",
            "@code": "3004"
        }
    ],
    "keywords": [
        "Asthma",
        "fixed-dose combination",
        "inhaled corticosteroid",
        "long-acting Beta2-agonist"
    ],
    "authors": [
        "Hiroshi Chantaphakul"
    ],
    "citedby-count": 6,
    "ref-count": 110,
    "ref-list": [
        "A look at the pathogenesis of asthma: the need for a change in direction.",
        "Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): A randomised, double-blind, placebo-controlled trial",
        "New perspectives in pharmacological treatment of mild persistent asthma",
        "Pharmacotherapy of patients with mild persistent asthma: Strategies and unresolved issues",
        "From the Global Strategy for Asthma Management and Prevention",
        "Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma",
        "Global Initiative for Asthma (GINA) guidelines: 15 years of application",
        "Pharmacotherapy of asthma: Regular treatment or on demand?",
        "Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone",
        "Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations",
        null,
        "Balancing the benefits and risks of inhaled long-acting beta-agonists - The influence of values",
        "The FDA and safe use of long-acting beta-agonists in the treatment of asthma",
        "Effect of inhaled formoterol and budesonide on exacerbations of asthma",
        "Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids",
        "Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid",
        "Leukotriene receptor antagonists pranlukast and montelukast for treating asthma",
        "Leukotrienes, antileukotrienes and asthma",
        null,
        null,
        null,
        null,
        null,
        null,
        "Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy",
        null,
        null,
        null,
        null,
        "Inhaled corticosteroids in lung diseases",
        "Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler",
        "Comparison of inhaled corticosteroids: An update",
        "A pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times",
        "Respiratory Tract Deposition of HFA-Beclomethasone and HFA-Fluticasone in Asthmatic Patients",
        "Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate",
        null,
        "New Zealand Drug Data Sheet",
        "New Zealand Drug Data Sheet",
        "New Zealand Drug Data Sheet",
        "New Zealand Drug Data Sheet",
        "New Zealand Drug Data Sheet",
        "MometasoneFormoterol inhalation aerosol: In asthma uncontrolled on medium-or high-dose inhaled corticosteroids",
        "New Zealand Drug Data Sheet",
        "Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients",
        "Risk-Benefit Value of Inhaled Glucocorticoids: A Pharmacokinetic/Pharmacodynamic Perspective",
        "Fluticasone furoate/fluticasone propionate - different drugs with different properties",
        "X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain",
        "Fluticasone furoate, a novel inhaled corticosteroid, demonstrates prolonged lung absorption kinetics in man compared with inhaled fluticasone propionate",
        "Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma",
        "Efficacy in asthma of once-daily treatment with fluticasone furoate: A randomized, placebo-controlled trial",
        "Fluticasone furoate: Once-daily evening treatment versus twice-daily treatment in moderate asthma",
        "Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: An 8-week, randomised, placebo-controlled trial",
        "Dose effect of once-daily fluticasone furoate in persistent asthma: A randomized trial",
        "Efficacy and Safety Profile of Fluticasone Furoate Administered Once Daily in the Morning or Evening: A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Trial in Adult and Adolescent Patients With Persistent Bronchial Asthma",
        "Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids",
        "Efficacy and safety of fluticasone furoate 100 \u03bcg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial",
        "Efficacy and safety of fluticasone furoate 100 \u03bcg and 200 \u03bcg once daily in the treatment of moderate-severe asthma in adults and adolescents: A 24-week randomised study",
        "Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: A 24-week placebo-controlled randomized trial",
        "Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: A 12-week randomized trial",
        "Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease",
        "The relationship between fluticasone furoate systemic exposure and cortisol suppression",
        "Salmeterol versus formoterol in patients with moderately severe asthma: Onset and duration of action",
        "Inhaled dry-powder formoterol and salmeterol in asthmatic patients: Onset of action, duration of effect and potency",
        "A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction",
        "Comparison of formoterol, salbutamol and salmeterol in methacholine- induced severe bronchoconstriction",
        "Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients",
        "Bronchodilating drugs for chronic obstructive pulmonary disease: Current status and future trends",
        null,
        "Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD",
        null,
        "Budesonide/formoterol: A review of its use in asthma",
        "Improved asthma control with budesonide/formeterol in a single inhaler, compared with budesonide alone",
        "Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma",
        "Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma",
        "Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing",
        "Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: A five-month multicentre Canadian study",
        "Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma",
        "Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: A randomized, double-blind trial",
        "Budesonide/formoterol for maintenance and reliever therapy in the management of moderate to severe asthma"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": []
}